Lite Strategy, Inc.
LITS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001262104
No open-market purchases or sales by Lite Strategy, Inc. insiders were filed in the last 90 days; 35 institutions reported holding it in 13F filings for Q2 2026, worth $5.43M in total; no superinvestor holds it.
Q2 2026 vs. Q1 2026
How the institutions holding Lite Strategy, Inc. changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Of which not filed for Q2 2026 | Q2 2026 | Change |
|---|---|---|---|---|
| Holders | 36 | 1 | 35 | 0 |
| Shares | 5.89M | 1 | 5.89M | −3.72K (−0.1%) |
| Value | $6.83M | $1 | $5.43M | −$1.40M (−20.5%) |
1 institution that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so the changes leave them out.
New holders (4)
Institutions that held Lite Strategy, Inc. at the end of Q2 2026 but not at the end of Q1 2026.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| RLH Capital LLC | 806,433 | $743.9K | 0.36% |
| Gsa Capital Partners LLP | 61,850 | $57.0K | 0.00% |
| Two Sigma Securities, LLC | 13,986 | $12.9K | 0.00% |
| Barclays PLC | 532 | $491 | 0.00% |
Sold out (4)
Institutions that held Lite Strategy, Inc. at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Bank Julius Baer & Co. Ltd, Zurich | 2,175 | $2.52K |
| MAI Capital Management | 75 | $87 |
| FMR LLC | 3 | $3 |
| Citigroup Inc | 1 | $1 |
Not filed for Q2 2026 yet (1)
Institutions that held Lite Strategy, Inc. at the end of Q1 2026 and haven't filed a 13F for Q2 2026. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| CWM, LLC | 1 | $1 |